Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-03-09

AUTHORS

A. Boquoi, S. M. Banahan, A. Mohring, I. Savickaite, J. Strapatsas, B. Hildebrandt, G. Kobbe, N. Gattermann, R. Haas, T. Schroeder, U. Germing, R. Fenk

ABSTRACT

Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) can be late complications following mutagenic treatment. Limited data is available on the outcome of patients developing therapy-related MDS and AML after treatment for multiple myeloma (MM). We identified 250 patients with therapy-associated MDS or AML in the Duesseldorf MDS registry. Of those, 50 patients were previously diagnosed with multiple myeloma (mm-MDS/AML). We compared them to patients with de novo MDS (n = 4862) and to patients with MDS following other underlying diseases (tMDS) (n = 200). mm-MDS patients and tMDS patients showed similar karyotypes and degrees of cytopenia. However, mm-MDS patients had significantly higher blast counts and more often belonged to the high-risk group according to the International Prognostic Scoring System (IPSS) (both p < 0.05). Although the rate of progression to AML was similar in mm-MDS and tMDS, both transformed significantly more often than de novo MDS (p < 0.05). Median overall survival of patients with mm-MDS (13 months; range: 1–99) and tMDS (13 months; range 0–160) was also similar yet significantly shorter than patients with de novo MDS (32 months; range 0–345 months; p < 0.05). Furthermore, survival of mm-MDS patients was not affected by myeloma activity. Despite significantly more high-risk disease and higher blast cell counts, myeloma-associated MDS-patients show features akin to other tMDS. Survival is similar to other tMDS and irrespective of myeloma remission status or transformation to AML. Thus, patient outcome is not determined by competing clones but rather by MDS governing the stem cell niche. More... »

PAGES

1031-1038

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-022-04775-1

DOI

http://dx.doi.org/10.1007/s00277-022-04775-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1146153631

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35262868


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Karyotyping", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Myeloma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myelodysplastic Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Second Primary", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boquoi", 
        "givenName": "A.", 
        "id": "sg:person.0774513574.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774513574.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Banahan", 
        "givenName": "S. M.", 
        "id": "sg:person.015330677013.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015330677013.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mohring", 
        "givenName": "A.", 
        "id": "sg:person.07675625555.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07675625555.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Savickaite", 
        "givenName": "I.", 
        "id": "sg:person.015674213733.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015674213733.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strapatsas", 
        "givenName": "J.", 
        "id": "sg:person.011330746150.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011330746150.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Human Genetics, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Institute of Human Genetics, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hildebrandt", 
        "givenName": "B.", 
        "id": "sg:person.01320675564.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320675564.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobbe", 
        "givenName": "G.", 
        "id": "sg:person.01164073234.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gattermann", 
        "givenName": "N.", 
        "id": "sg:person.01273447501.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273447501.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haas", 
        "givenName": "R.", 
        "id": "sg:person.01127414674.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Stem Cell Transplantation, University Medicine Essen, Essen, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology and Stem Cell Transplantation, University Medicine Essen, Essen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schroeder", 
        "givenName": "T.", 
        "id": "sg:person.01271136615.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Germing", 
        "givenName": "U.", 
        "id": "sg:person.01362464041.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fenk", 
        "givenName": "R.", 
        "id": "sg:person.01177747626.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177747626.74"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/s41375-020-0917-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1128827022", 
          "https://doi.org/10.1038/s41375-020-0917-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403187", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022486557", 
          "https://doi.org/10.1038/sj.leu.2403187"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-03-09", 
    "datePublishedReg": "2022-03-09", 
    "description": "Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) can be late complications following mutagenic treatment. Limited data is available on the outcome of patients developing therapy-related MDS and AML after treatment for multiple myeloma (MM). We identified 250 patients with therapy-associated MDS or AML in the Duesseldorf MDS registry. Of those, 50 patients were previously diagnosed with multiple myeloma (mm-MDS/AML). We compared them to patients with de novo MDS (n\u2009=\u20094862) and to patients with MDS following other underlying diseases (tMDS) (n\u2009=\u2009200). mm-MDS patients and tMDS patients showed similar karyotypes and degrees of cytopenia. However, mm-MDS patients had significantly higher blast counts and more often belonged to the high-risk group according to the International Prognostic Scoring System (IPSS) (both p\u2009<\u20090.05). Although the rate of progression to AML was similar in mm-MDS and tMDS, both transformed significantly more often than de novo MDS (p\u2009<\u20090.05). Median overall survival of patients with mm-MDS (13\u00a0months; range: 1\u201399) and tMDS (13\u00a0months; range 0\u2013160) was also similar yet significantly shorter than patients with de novo MDS (32\u00a0months; range 0\u2013345\u00a0months; p\u2009<\u20090.05). Furthermore, survival of mm-MDS patients was not affected by myeloma activity. Despite significantly more high-risk disease and higher blast cell counts, myeloma-associated MDS-patients show features akin to other tMDS. Survival is similar to other tMDS and irrespective of myeloma remission status or transformation to AML. Thus, patient outcome is not determined by competing clones but rather by MDS governing the stem cell niche.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-022-04775-1", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "101"
      }
    ], 
    "keywords": [
      "de novo myelodysplastic syndrome", 
      "acute myeloid leukemia", 
      "novo myelodysplastic syndrome", 
      "International Prognostic Scoring System", 
      "myelodysplastic syndrome", 
      "multiple myeloma", 
      "MDS patients", 
      "high blast cell counts", 
      "therapy-related myelodysplastic syndrome", 
      "therapy-related myeloid neoplasms", 
      "Duesseldorf MDS Registry", 
      "outcomes of patients", 
      "median overall survival", 
      "single-center analysis", 
      "prognostic scoring system", 
      "high-risk disease", 
      "blast cell count", 
      "high-risk group", 
      "degree of cytopenia", 
      "rate of progression", 
      "high blast count", 
      "MDS Registry", 
      "late complications", 
      "blast count", 
      "overall survival", 
      "myeloma activity", 
      "remission status", 
      "patient outcomes", 
      "myeloid leukemia", 
      "myeloid neoplasms", 
      "patients", 
      "cell count", 
      "myeloma", 
      "scoring system", 
      "center analysis", 
      "limited data", 
      "survival", 
      "treatment", 
      "disease", 
      "outcomes", 
      "stem cell niche", 
      "count", 
      "cytopenias", 
      "complications", 
      "registry", 
      "neoplasms", 
      "syndrome", 
      "cell niche", 
      "leukemia", 
      "progression", 
      "status", 
      "group", 
      "karyotype", 
      "activity", 
      "clones", 
      "rate", 
      "TMDS", 
      "mutagenic treatment", 
      "data", 
      "degree", 
      "analysis", 
      "niche", 
      "system", 
      "similar karyotypes", 
      "transformation"
    ], 
    "name": "Therapy-related myeloid neoplasms following treatment for multiple myeloma\u2014a single center analysis", 
    "pagination": "1031-1038", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1146153631"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-022-04775-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35262868"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-022-04775-1", 
      "https://app.dimensions.ai/details/publication/pub.1146153631"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_928.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-022-04775-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-022-04775-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-022-04775-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-022-04775-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-022-04775-1'


 

This table displays all metadata directly associated to this object as RDF triples.

245 TRIPLES      21 PREDICATES      99 URIs      88 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-022-04775-1 schema:about N00c1d7b27216410aaa31bea7489de2cf
2 N8c78882a2442442da3c35cb695ff67a5
3 N8fed6d5c278945869232c871ab5b4737
4 Na37a1a7d19684dc4960792e60617c182
5 Nec5414eec7614408b15afc77e9695d6c
6 Nf606fe3ddac34b048a325c6b17fe4f30
7 anzsrc-for:11
8 anzsrc-for:1102
9 anzsrc-for:1112
10 schema:author N08a6bc8309c94e4099f444c5489b6f32
11 schema:citation sg:pub.10.1038/s41375-020-0917-7
12 sg:pub.10.1038/sj.leu.2403187
13 schema:datePublished 2022-03-09
14 schema:datePublishedReg 2022-03-09
15 schema:description Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) can be late complications following mutagenic treatment. Limited data is available on the outcome of patients developing therapy-related MDS and AML after treatment for multiple myeloma (MM). We identified 250 patients with therapy-associated MDS or AML in the Duesseldorf MDS registry. Of those, 50 patients were previously diagnosed with multiple myeloma (mm-MDS/AML). We compared them to patients with de novo MDS (n = 4862) and to patients with MDS following other underlying diseases (tMDS) (n = 200). mm-MDS patients and tMDS patients showed similar karyotypes and degrees of cytopenia. However, mm-MDS patients had significantly higher blast counts and more often belonged to the high-risk group according to the International Prognostic Scoring System (IPSS) (both p < 0.05). Although the rate of progression to AML was similar in mm-MDS and tMDS, both transformed significantly more often than de novo MDS (p < 0.05). Median overall survival of patients with mm-MDS (13 months; range: 1–99) and tMDS (13 months; range 0–160) was also similar yet significantly shorter than patients with de novo MDS (32 months; range 0–345 months; p < 0.05). Furthermore, survival of mm-MDS patients was not affected by myeloma activity. Despite significantly more high-risk disease and higher blast cell counts, myeloma-associated MDS-patients show features akin to other tMDS. Survival is similar to other tMDS and irrespective of myeloma remission status or transformation to AML. Thus, patient outcome is not determined by competing clones but rather by MDS governing the stem cell niche.
16 schema:genre article
17 schema:isAccessibleForFree true
18 schema:isPartOf N760cbefaa821439682f3c4738e40042e
19 N95f3b1e61ba04734a7d7328a937a91a4
20 sg:journal.1358129
21 schema:keywords Duesseldorf MDS Registry
22 International Prognostic Scoring System
23 MDS Registry
24 MDS patients
25 TMDS
26 activity
27 acute myeloid leukemia
28 analysis
29 blast cell count
30 blast count
31 cell count
32 cell niche
33 center analysis
34 clones
35 complications
36 count
37 cytopenias
38 data
39 de novo myelodysplastic syndrome
40 degree
41 degree of cytopenia
42 disease
43 group
44 high blast cell counts
45 high blast count
46 high-risk disease
47 high-risk group
48 karyotype
49 late complications
50 leukemia
51 limited data
52 median overall survival
53 multiple myeloma
54 mutagenic treatment
55 myelodysplastic syndrome
56 myeloid leukemia
57 myeloid neoplasms
58 myeloma
59 myeloma activity
60 neoplasms
61 niche
62 novo myelodysplastic syndrome
63 outcomes
64 outcomes of patients
65 overall survival
66 patient outcomes
67 patients
68 prognostic scoring system
69 progression
70 rate
71 rate of progression
72 registry
73 remission status
74 scoring system
75 similar karyotypes
76 single-center analysis
77 status
78 stem cell niche
79 survival
80 syndrome
81 system
82 therapy-related myelodysplastic syndrome
83 therapy-related myeloid neoplasms
84 transformation
85 treatment
86 schema:name Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis
87 schema:pagination 1031-1038
88 schema:productId N27f07a77f2fe48549dcc0116e7ca2af1
89 N341eeaa8b195410e9419d34f47c15808
90 Na7c4df81d5834ab8b806a707749395e3
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1146153631
92 https://doi.org/10.1007/s00277-022-04775-1
93 schema:sdDatePublished 2022-08-04T17:12
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N1d0f9c39dc414b5ea735b1eeb41cdb40
96 schema:url https://doi.org/10.1007/s00277-022-04775-1
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N00c1d7b27216410aaa31bea7489de2cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Multiple Myeloma
102 rdf:type schema:DefinedTerm
103 N08a6bc8309c94e4099f444c5489b6f32 rdf:first sg:person.0774513574.12
104 rdf:rest N58dc04c5123448eb8ed8ed113dd38a3f
105 N0e29b3f0fde2437496ce11de217dd9ad rdf:first sg:person.01320675564.15
106 rdf:rest Na232cb0b98e94561ac23d67287eb88af
107 N10e90f2145db436eba958e749d92c0b2 rdf:first sg:person.07675625555.23
108 rdf:rest Nb458f519f22a4503b744959916f8f127
109 N1d0f9c39dc414b5ea735b1eeb41cdb40 schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N21e80b4f2bfe40ef87241e03e37def50 rdf:first sg:person.01362464041.20
112 rdf:rest N3cae3d38908b4d11aaca5ca0d13cf3ff
113 N27f07a77f2fe48549dcc0116e7ca2af1 schema:name doi
114 schema:value 10.1007/s00277-022-04775-1
115 rdf:type schema:PropertyValue
116 N341eeaa8b195410e9419d34f47c15808 schema:name dimensions_id
117 schema:value pub.1146153631
118 rdf:type schema:PropertyValue
119 N3cae3d38908b4d11aaca5ca0d13cf3ff rdf:first sg:person.01177747626.74
120 rdf:rest rdf:nil
121 N58dc04c5123448eb8ed8ed113dd38a3f rdf:first sg:person.015330677013.69
122 rdf:rest N10e90f2145db436eba958e749d92c0b2
123 N72c67a754ee5486bb16c99131b0f86da rdf:first sg:person.01273447501.34
124 rdf:rest Nd03b25330e5c4d5f855a2f50fb5321c1
125 N760cbefaa821439682f3c4738e40042e schema:volumeNumber 101
126 rdf:type schema:PublicationVolume
127 N8b80708b38124f2b9ab781e7baf1956c rdf:first sg:person.011330746150.14
128 rdf:rest N0e29b3f0fde2437496ce11de217dd9ad
129 N8c78882a2442442da3c35cb695ff67a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Humans
131 rdf:type schema:DefinedTerm
132 N8fed6d5c278945869232c871ab5b4737 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Leukemia, Myeloid, Acute
134 rdf:type schema:DefinedTerm
135 N949b75cc13ac4cda888fd9887e3f1494 rdf:first sg:person.01271136615.68
136 rdf:rest N21e80b4f2bfe40ef87241e03e37def50
137 N95f3b1e61ba04734a7d7328a937a91a4 schema:issueNumber 5
138 rdf:type schema:PublicationIssue
139 Na232cb0b98e94561ac23d67287eb88af rdf:first sg:person.01164073234.53
140 rdf:rest N72c67a754ee5486bb16c99131b0f86da
141 Na37a1a7d19684dc4960792e60617c182 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Myelodysplastic Syndromes
143 rdf:type schema:DefinedTerm
144 Na7c4df81d5834ab8b806a707749395e3 schema:name pubmed_id
145 schema:value 35262868
146 rdf:type schema:PropertyValue
147 Nb458f519f22a4503b744959916f8f127 rdf:first sg:person.015674213733.39
148 rdf:rest N8b80708b38124f2b9ab781e7baf1956c
149 Nd03b25330e5c4d5f855a2f50fb5321c1 rdf:first sg:person.01127414674.14
150 rdf:rest N949b75cc13ac4cda888fd9887e3f1494
151 Nec5414eec7614408b15afc77e9695d6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Karyotyping
153 rdf:type schema:DefinedTerm
154 Nf606fe3ddac34b048a325c6b17fe4f30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Neoplasms, Second Primary
156 rdf:type schema:DefinedTerm
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
161 schema:name Cardiorespiratory Medicine and Haematology
162 rdf:type schema:DefinedTerm
163 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
164 schema:name Oncology and Carcinogenesis
165 rdf:type schema:DefinedTerm
166 sg:journal.1358129 schema:issn 0939-5555
167 1432-0584
168 schema:name Annals of Hematology
169 schema:publisher Springer Nature
170 rdf:type schema:Periodical
171 sg:person.01127414674.14 schema:affiliation grid-institutes:grid.14778.3d
172 schema:familyName Haas
173 schema:givenName R.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14
175 rdf:type schema:Person
176 sg:person.011330746150.14 schema:affiliation grid-institutes:grid.14778.3d
177 schema:familyName Strapatsas
178 schema:givenName J.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011330746150.14
180 rdf:type schema:Person
181 sg:person.01164073234.53 schema:affiliation grid-institutes:grid.14778.3d
182 schema:familyName Kobbe
183 schema:givenName G.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53
185 rdf:type schema:Person
186 sg:person.01177747626.74 schema:affiliation grid-institutes:grid.14778.3d
187 schema:familyName Fenk
188 schema:givenName R.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177747626.74
190 rdf:type schema:Person
191 sg:person.01271136615.68 schema:affiliation grid-institutes:None
192 schema:familyName Schroeder
193 schema:givenName T.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68
195 rdf:type schema:Person
196 sg:person.01273447501.34 schema:affiliation grid-institutes:grid.14778.3d
197 schema:familyName Gattermann
198 schema:givenName N.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273447501.34
200 rdf:type schema:Person
201 sg:person.01320675564.15 schema:affiliation grid-institutes:grid.411327.2
202 schema:familyName Hildebrandt
203 schema:givenName B.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320675564.15
205 rdf:type schema:Person
206 sg:person.01362464041.20 schema:affiliation grid-institutes:grid.14778.3d
207 schema:familyName Germing
208 schema:givenName U.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20
210 rdf:type schema:Person
211 sg:person.015330677013.69 schema:affiliation grid-institutes:grid.14778.3d
212 schema:familyName Banahan
213 schema:givenName S. M.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015330677013.69
215 rdf:type schema:Person
216 sg:person.015674213733.39 schema:affiliation grid-institutes:grid.14778.3d
217 schema:familyName Savickaite
218 schema:givenName I.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015674213733.39
220 rdf:type schema:Person
221 sg:person.07675625555.23 schema:affiliation grid-institutes:grid.14778.3d
222 schema:familyName Mohring
223 schema:givenName A.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07675625555.23
225 rdf:type schema:Person
226 sg:person.0774513574.12 schema:affiliation grid-institutes:grid.14778.3d
227 schema:familyName Boquoi
228 schema:givenName A.
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774513574.12
230 rdf:type schema:Person
231 sg:pub.10.1038/s41375-020-0917-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128827022
232 https://doi.org/10.1038/s41375-020-0917-7
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/sj.leu.2403187 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022486557
235 https://doi.org/10.1038/sj.leu.2403187
236 rdf:type schema:CreativeWork
237 grid-institutes:None schema:alternateName Department of Hematology and Stem Cell Transplantation, University Medicine Essen, Essen, Germany
238 schema:name Department of Hematology and Stem Cell Transplantation, University Medicine Essen, Essen, Germany
239 rdf:type schema:Organization
240 grid-institutes:grid.14778.3d schema:alternateName Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany
241 schema:name Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany
242 rdf:type schema:Organization
243 grid-institutes:grid.411327.2 schema:alternateName Institute of Human Genetics, Heinrich-Heine-University, Duesseldorf, Germany
244 schema:name Institute of Human Genetics, Heinrich-Heine-University, Duesseldorf, Germany
245 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...